142 related articles for article (PubMed ID: 31962263)
21. Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Maillard LT; Bertout S; Quinonéro O; Akalin G; Turan-Zitouni G; Fulcrand P; Demirci F; Martinez J; Masurier N
Bioorg Med Chem Lett; 2013 Mar; 23(6):1803-7. PubMed ID: 23403080
[TBL] [Abstract][Full Text] [Related]
22.
Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
[No Abstract] [Full Text] [Related]
23. Synthesis of benzofuro[6,7-d]thiazoles, benzofuro[7,6-d]thiazoles and 6-arylaminobenzo[d]thiazole-4,7-diones as antifungal agent.
Ryu CK; Nho JH; Jin G; Oh SY; Choi SJ
Chem Pharm Bull (Tokyo); 2014; 62(7):668-74. PubMed ID: 24789966
[TBL] [Abstract][Full Text] [Related]
24. Aryl-alkyl-lysines: Membrane-Active Fungicides That Act against Biofilms of Candida albicans.
Ghosh C; Yadav V; Younis W; Mohammad H; Hegazy YA; Seleem MN; Sanyal K; Haldar J
ACS Infect Dis; 2017 Apr; 3(4):293-301. PubMed ID: 28238268
[TBL] [Abstract][Full Text] [Related]
25. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
Bassetti M; Vena A; Bouza E; Peghin M; Muñoz P; Righi E; Pea F; Lackner M; Lass-Flörl C
Clin Microbiol Infect; 2020 Aug; 26(8):1024-1033. PubMed ID: 32120042
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
28. Antifungal and antiprotozoal green amino acid-based rhamnolipids: Mode of action, antibiofilm efficiency and selective activity against resistant Candida spp. strains and Acanthamoeba castellanii.
da Silva A; Nobre H; Sampaio L; Nascimento BD; da Silva C; de Andrade Neto JB; Manresa Á; Pinazo A; Cavalcanti B; de Moraes MO; Ruiz-Trillo I; Antó M; Morán C; Pérez L
Colloids Surf B Biointerfaces; 2020 Sep; 193():111148. PubMed ID: 32512371
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel thiazolyl-phenyl-thiazole derivatives as promising anti-Candida agents.
Borcea AM; Marc G; Vodnar DC; Vlase L; Oniga O
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2085-2090. PubMed ID: 30393216
[TBL] [Abstract][Full Text] [Related]
30. Antifungal and anti-biofilm effects of 6-shogaol against Candida auris.
Kim HR; Eom YB
J Appl Microbiol; 2021 Apr; 130(4):1142-1153. PubMed ID: 32981148
[TBL] [Abstract][Full Text] [Related]
31. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
35. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
Jabra-Rizk MA; Shirtliff M; James C; Meiller T
FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of some novel 3-(1-(1-substitutedpiperidin-4-yl)-1H-1,2,3-triazol-4-yl)-5-substituted phenyl-1,2,4-oxadiazoles as antifungal agents.
Sangshetti JN; Shinde DB
Eur J Med Chem; 2011 Apr; 46(4):1040-4. PubMed ID: 21324567
[TBL] [Abstract][Full Text] [Related]
37. [Activity of micafungin against Candida biofilms].
Quindós G; Villar-Vidal M; Eraso E
Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
[TBL] [Abstract][Full Text] [Related]
38. Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms.
Oliveira AS; Martinez-de-Oliveira J; Donders GGG; Palmeira-de-Oliveira R; Palmeira-de-Oliveira A
Med Microbiol Immunol; 2018 Aug; 207(3-4):195-200. PubMed ID: 29556778
[TBL] [Abstract][Full Text] [Related]
39. Syntheses and antifungal activities of novel 3-amido bearing pseudomycin analogues.
Zhang YZ; Sun X; Zeckner DJ; Sachs RK; Current WL; Gidda J; Rodriguez M; Chen SH
Bioorg Med Chem Lett; 2001 Apr; 11(7):903-7. PubMed ID: 11294388
[TBL] [Abstract][Full Text] [Related]
40. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Pfaller MA; Messer SA; Jones RN; Castanheira M
J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
